Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT05305690 |
Other study ID # |
19-0647 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
May 1, 2016 |
Est. completion date |
January 3, 2023 |
Study information
Verified date |
March 2022 |
Source |
Poudre Valley Health System |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The goal of this study is to evaluate a series of cases of penetrating cerebrovascular injury
managed without upfront operation. Investigators focus on patient characteristics, injury
details, treatment modalities, serial imaging studies, patient outcomes, and complications.
Investigators will compare this patient population to patients managed with upfront operation
for context.
Description:
Penetrating cerebrovascular injuries (PCVIs) are uncommon, with little data to guide
management when emergent operative repair is not performed. Investigators hypothesized that
PCVIs may be managed with antithrombotic therapy and directed use of endovascular
interventions, but that PCVIs may require enhanced surveillance due to a risk of delayed
complications. To perform this study, investigators will review patients with penetrating
carotid and vertebral artery injuries managed at an urban Level I trauma center from 2016 to
2022. Patients will be included if they underwent initial nonoperative management (NOM).
Patient characteristics, injury details, treatments, serial imaging, outcomes, and
complications will be assessed in a retrospective manner using chart abstraction.
Investigators will briefly compare these patients to those managed with upfront operations
for context.